Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

Luxa's stem cell therapy for dry AMD shows early promise

2 months ago

Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies

2 months ago

Alcon tried to sink Aurion's IPO in 'Valentine's Day massacre,' new lawsuits say

2 months ago

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

3 months ago

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

3 months ago

Will CRISPR matter?

3 months ago

Thermo Fisher to lay off 300 workers at two viral vector factories

3 months ago

Cargo Therapeutics cuts lead CAR-T program, 50% of staff

3 months ago

Judge's ruling clears way for Aurion Biotech's IPO, investor Alcon to appeal

3 months ago

Updated: Cell therapy biotech Affini-T Therapeutics reduces staff

3 months ago

Cell therapy startup Aurion files for IPO, despite ongoing legal battle with investor Alcon

3 months ago

UK biotech launches with T cell therapy technology to treat solid tumors

3 months ago

Chinese startup begins first trial of in vivo CRISPR therapy for blood disease

4 months ago

FDA rejects Atara's cell therapy for rare transplant complication, stock craters

4 months ago

Vertex's bid to offer Casgevy fertility support is 'self-serving,' HHS says

4 months ago

Umoja’s $100M Series C will advance its bid for more convenient cell therapies

4 months ago

Post-Hoc: The embryo editing debate is back

4 months ago

Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic

4 months ago

Shoreline cuts staff as its partnership with Gilead's Kite is now in flux

4 months ago

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

4 months ago

Astellas stops developing autologous cell therapy using tech from Xyphos buyout

4 months ago

Vertex signs in vivo gene editing delivery pact for sickle cell and thalassemia as it looks beyond Casgevy

4 months ago

Pfizer ends work on Sangamo's hemophilia gene therapy, crushing biotech's hopes

4 months ago

WuXi AppTec will sell cell and gene therapy business to private equity firm

5 months ago

First page Previous page 1 234 5 6 Next page Last page